NASDAQ: TRAW
Traws Pharma Inc Stock Forecast, Predictions & Price Target

Be the first to know when Wall Street analysts revise their TRAW stock forecasts and price targets.

Forecast return on equity

Is TRAW forecast to generate an efficient return?

Company
-2,479.44%
Industry
127.2%
Market
-48.11%
TRAW's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is TRAW forecast to generate an efficient return on assets?

Company
-1,311.3%
Industry
47.5%
TRAW is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

TRAW revenue growth forecast

How is TRAW forecast to perform vs Biotechnology companies and vs the US market?

Company
-52.47%
Industry
79.33%
Market
10.78%
TRAW's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
TRAW's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

TRAW vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
TRAW$1.34N/AN/A
LIXT$3.48N/AN/A
APRE$1.59N/AN/A
DWTX$4.81$10.00+107.90%Buy
BOLT$4.78$50.00+945.15%Buy

Traws Pharma Stock Forecast FAQ

What is TRAW's forecast return on equity (ROE) for 2025-2028?

(NASDAQ: TRAW) forecast ROE is -2,479.44%, which is considered weak.

If you're new to stock investing, here's how to buy Traws Pharma stock.

What is TRAW's forecast return on assets (ROA) for 2025-2028?

(NASDAQ: TRAW) forecast ROA is -1,311.3%, which is lower than the forecast US Biotechnology industry average of 47.5%.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.